ArticleHealthcare (Basel, Switzerland)2021
Propensity Score Analysis Assessing the Burden of Non-Communicable Diseases among the Transgender Population in the United States Using the Behavioral Risk Factor Surveillance System (2017-2019).
Article in Healthcare (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Mapping the cardiovascular burden in transgender individuals: a systematic review and meta-analysis.Frontiers in public health · 2026Pooled it
- Encapsulating the burden and social determinants of self-reported general health problems among a specific sub-group of transgender women in Dhaka, Bangladesh: a mixed-methods study.International journal for equity in health · 2026Article
- Validation of a Methodology to Investigate Care Inequities for Transgender Patients.The western journal of emergency medicine · 2025Observational
- Lifestyle behaviors and cardiovascular risk factors in transgender versus cisgender stroke survivors.PloS one · 2025Article
- Social-Ecological Determinants of Suicidal Ideation Among Sexual and Gender Minority Adults: A Cross-Sectional Study in the United States.Healthcare (Basel, Switzerland) · 2024Article
- Non-communicable diseases and its risk factors among the transgender population in Kerala: a cross-sectional study.International journal for equity in health · 2024Article
- The impact of gender-affirming hormone therapy on nutrition-relevant biochemical measures.Frontiers in nutrition · 2024Review
- Sex and gender differences in risk scores for dementia and Alzheimer's disease among cisgender, transgender, and non-binary adults.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024Observational
- Experiences of transgender persons in accessing routine healthcare services in India: Findings from a participatory qualitative study.PLOS global public health · 2024Article
- Hypertension in transgender individuals.Journal of human hypertension · 2023Review
- Epidemiology of non-communicable diseases among transgender population residing in Chennai district, Tamil Nadu.Journal of family medicine and primary care · 2023Article
- Impact of COVID-19 on Sexual and Gender Minority Communities: Focus Group Discussions.International journal of environmental research and public health · 2022Article
- The Continued Importance of Including Transgender Individuals in HIV-Related Research.AIDS research and human retroviruses · 2022Article
- Physical and Mental Disabilities among the Gender-Diverse Population Using the Behavioral Risk Factor Surveillance System, BRFSS (2017-2019): A Propensity-Matched Analysis.Healthcare (Basel, Switzerland) · 2021Article
- Using concept mapping to identify recruitment and engagement strategies for inclusion of LGBTQIA+ populations in Alzheimer's disease and related dementia research.Alzheimer's & dementia (New York, N. Y.)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Research to assess the burden of non-communicable diseases (NCDs) among the transgender population needs to be prioritized given the high prevalence of chronic conditions and associated risk factors in this group. Previous cross-sectional studies utilized unmatched samples with a significant covariate imbalance resulting in a selection bias. Therefore, this cross-sectional study attempts to assess and compare the burden of NCDs among propensity score-matched transgender and cisgender population groups. This study analyzed Behavioral Risk Factor Surveillance System data (2017-2019) using complex weighting procedures to generate nationally representative samples. Logistic regression was fit to estimate propensity scores. Transgender and cisgender groups were matched by sociodemographic variables using a 1:1 nearest neighbor matching algorithm. McNemar, univariate, and multivariate logistic regression analyses were conducted among matched cohorts using R and SPSS version 26 software. Compared with the cisgender group, the transgender group was significantly more likely to have hypertension (31.3% vs. 27.6%), hypercholesteremia (30.8% vs. 23.7%), prediabetes (17.3% vs. 10.3%), and were heavy drinkers (6.7% vs. 6.0%) and smokers (22.4% vs. 20.0%). Moreover, the transgender group was more than twice as likely to have depression (aOR: 2.70, 95% CI 2.62-2.72), stroke (aOR: 2.52 95% CI 2.50-2.55), coronary heart disease (aOR: 2.77, 95% CI 2.74-2.81), and heart attack (aOR: 2.90, 95% CI 2.87-2.94). Additionally, the transgender group was 1.2-1.7 times more likely to have metabolic and malignant disorders. Differences were also found between transgender subgroups compared with the cisgender group. This study provides a clear picture of the NCD burden among the transgender population. These findings offer an evidence base to build health equity models to reduce disparities among transgender groups.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.